Transmission potential of <i>Streptococcus pyogenes</i> during a controlled human infection trial of pharyngitis

Controlled human infection (CHI) models can provide insights into transmission of pathogens such as <i>Streptococcus pyogenes</i> (Strep A). As part of the Controlled Human Infection with Penicillin for <i>Streptococcus pyogenes</i> (CHIPS) trial, we explored the potential for transmission among participants deliberately infected with the Strep A emm75 strain. Three approaches to understanding transmission were employed: the use of agar settle plates to capture possible droplet or airborne spread of Strep A; measurement of distance droplets could spread during conversation; and environmental swabbing of high-touch items to detect Strep A on surfaces. Of the 60 (27%) CHIPS trial participants across five cohorts, 16 were enrolled in this sub-study; availability of study staff was the primary reason for selection. In total, 189 plates and 260 swabs were collected. Strep A was grown on one settle plate from a participant on the second day, using plates placed 30 cm away. This participant received the placebo dose of penicillin and had met the primary endpoint of pharyngitis. Whole-genome sequencing identified this to be the challenge strain. Strep A was not detected on any swabs. In this small sample of CHI participants, we did not find evidence of Strep A transmission by the airborne route or fomites, and just one instance of droplet spread while acutely symptomatic with streptococcal pharyngitis. Although these experiments provide evidence of minimal transmission within controlled clinical settings, greater efforts are required to explore Strep A transmission in naturalistic settings.IMPORTANCE<i>Streptococcus pyogenes</i> remains a significant driver of morbidity and mortality, particularly in under-resourced settings. Understanding the transmission modalities of this pathogen is essential to ensuring the success of prevention methods. This proposed paper presents a nascent attempt to determine the transmission potential of <i>Streptococcus pyogenes</i> nested within a larger controlled human infection model.

Authors

Institutions

Publication Details

Journal
mSphere
Published
2024-09-10
DOI
https://doi.org/10.1128/msphere.00513-24
Citations
2
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
1.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transmission potential of Streptococcus pyogenes during a controlled human infection trial of pharyngitis

Laurens Manning, Nina Lansbury, Jonathan Rhys Carapetis, Hannah M. M. Thomas et al.
2 citations
mSphere
Streptococcal Infections and Treatments
1.09
article

Transmission potential of Streptococcus pyogenes during a controlled human infection trial of pharyngitis

Laurens Manning, Nina Lansbury, Jonathan Rhys Carapetis, Hannah M. M. Thomas, Joshua Osowicki, Janessa L. Pickering, Thel K. Hla, Andrew C. Steer, Asha C Bowen, Stephanie Enkel, Timothy C. Barnett, Bernadette Z.Y. Wong
article en
2 citations

Abstract

Controlled human infection (CHI) models can provide insights into transmission of pathogens such as <i>Streptococcus pyogenes</i> (Strep A). As part of the Controlled Human Infection with Penicillin for <i>Streptococcus pyogenes</i> (CHIPS) trial, we explored the potential for transmission among participants deliberately infected with the Strep A emm75 strain. Three approaches to understanding transmission were employed: the use of agar settle plates to capture possible droplet or airborne spread of Strep A; measurement of distance droplets could spread during conversation; and environmental swabbing of high-touch items to detect Strep A on surfaces. Of the 60 (27%) CHIPS trial participants across five cohorts, 16 were enrolled in this sub-study; availability of study staff was the primary reason for selection. In total, 189 plates and 260 swabs were collected. Strep A was grown on one settle plate from a participant on the second day, using plates placed 30 cm away. This participant received the placebo dose of penicillin and had met the primary endpoint of pharyngitis. Whole-genome sequencing identified this to be the challenge strain. Strep A was not detected on any swabs. In this small sample of CHI participants, we did not find evidence of Strep A transmission by the airborne route or fomites, and just one instance of droplet spread while acutely symptomatic with streptococcal pharyngitis. Although these experiments provide evidence of minimal transmission within controlled clinical settings, greater efforts are required to explore Strep A transmission in naturalistic settings.IMPORTANCE<i>Streptococcus pyogenes</i> remains a significant driver of morbidity and mortality, particularly in under-resourced settings. Understanding the transmission modalities of this pathogen is essential to ensuring the success of prevention methods. This proposed paper presents a nascent attempt to determine the transmission potential of <i>Streptococcus pyogenes</i> nested within a larger controlled human infection model.

mSphereVol. 9(10)
Royal Children's Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), The Kids Research Institute Australia (AU), The University of Western Australia (AU), Princess Margaret Hospital for Children (AU), Fiona Stanley Hospital (AU), Murdoch Children's Research Institute (AU), Perth Children's Hospital
Good health and well-being
Openalex Percentile: Top 21%
Streptococcal Infections and Treatments
1.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.